Tscan therapeutics presents phase 1 umbrella trial in progress on ha-1 (tsc-100) and ha-2 (tsc-101) at the 64th american society of hematology annual meeting 2022

Poster presents phase 1 trial design and translational assays to generate early evidence of biological activity in residual leukemia after hematopoietic cell transplantation poster presents phase 1 trial design and translational assays to generate early evidence of biological activity in residual leukemia after hematopoietic cell transplantation
TCRX Ratings Summary
TCRX Quant Ranking